Eye Journal
SPARCS and Pelli–Robson contrast sensitivity testing in normal controls and patients with cataract – (Eye 31, 753 (May 2017))
SPARCS and Pelli–Robson contrast sensitivity testing in normal controls and patients with cataract Eye 31, 753 (May 2017). doi:10.1038/eye.2016.319 Authors: L Gupta, V Cvintal, R Delvadia, Y Sun, E Erdem, C Zangalli, L Lu, S S Wizov, J Richman, E Spaeth & G L Spaeth
The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF – (Eye 31, 762 (May 2017))
The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF Eye 31, 762 (May 2017). doi:10.1038/eye.2016.317 Authors: C-K Chang, C-K Cheng & C-H Peng
Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome – (Eye 31, 771 (May 2017))
Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome Eye 31, 771 (May 2017). doi:10.1038/eye.2017.1 Authors: B Foot & C MacEwen
Patching retinal breaks with Seprafilm for treating retinal detachments in humans: 9 years of follow-up – (Eye 31, 776 (May 2017))
Patching retinal breaks with Seprafilm for treating retinal detachments in humans: 9 years of follow-up Eye 31, 776 (May 2017). doi:10.1038/eye.2016.329 Authors: M Haruta, M Arai, J Sueda, T Hirose & R Yamakawa
Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis – (Eye 31, 781 (May 2017))
Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis Eye 31, 781 (May 2017). doi:10.1038/eye.2017.4 Authors: L Asena, E Şıngar Özdemir, A Burcu, E Ercan, M Çolak & D D Altınörs